Smith Micro Reports Second Quarter 2026 Financial Results

SMITH MICRO SOFTWARE, INC. (SMSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 IR INQUIRIES: Charles Messman Investor Relations 412-837-5300 IR@smithmicro.com Smith Micro Reports Second Quarter 2026 Financial Results PITTSBURGH, PA, August 13, 2026 – Smith Micro Software, Inc. ( Nasdaq: SMSI ) (“Smith Micro” or the “Company”) today reported fin

Original reporting
Published Aug 13, 2026, 8:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 8:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SMSI
Bullish
medium confidence
Mentioned
$SMSI
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SMSIBullishMed
01

Why it matters

Traders can reassess near-term fundamentals using the reported revenue, gross margin, and GAAP/non-GAAP loss figures, and monitor the investor call for any additional detail on pipeline conversion and SafePath Connect adoption.

02

Market read

Fresh quarterly results with a notable gross margin expansion and reduced losses, plus forward-looking product and pipeline commentary ahead of the investor call.

03

What to watch

The reverse stock split (effective June 4, 2026) affects per-share comparisons; investors may also focus on cash burn trajectory and contract timing risk behind the “near term” customer launches.

Relevance 7/10Novelty 7/10Timing: today’s 8-K with Q2 2026 results and an investor call at 4:30 p.m. ET

Background

This is an SEC Form 8-K (Item 2.02) attaching a press release with Smith Micro’s Q2 2026 financial results and management commentary.

Company-level read

Ticker impact

$SMSIBullishMedium confidence
Context

Smith Micro reported Q2 2026 revenue of $4.3M and narrowed GAAP net loss to $2.7M, alongside higher gross margin.

Expected impact

Near-term bias to stabilize or re-rate the stock if investors focus on sequential revenue growth and gross margin expansion, but losses remain sizable.

Evidence & confidence

Revenue is slightly down YoY, but gross margin rose sharply and GAAP/non-GAAP losses improved materially versus the prior year period. The article does not provide guidance numbers, so the impact likely hinges on investor interpretation of momentum and pipeline claims.

Market effects

Signals improving profitability metrics for a niche mobile software provider, but does not change broader sector fundamentals.

Limited, company-specific impact with no regional macro linkage.

Low global relevance; primarily affects Smith Micro’s own valuation and sentiment.

Counterpoint

Despite margin improvement, revenue declined YoY and cash is low ($2.8M), so the market may discount momentum claims without quantified guidance.

Key entities

  • Smith Micro Software, Inc.

    Nasdaq-listed mobile software provider reporting Q2 2026 results and discussing SafePath Connect, SDK/API deployment options, and pipeline momentum.

Related articles

$SMSIMed

Smith Micro Reports Third Quarter 2026 Financial Results

SMITH MICRO SOFTWARE, INC. (SMSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 IR INQUIRIES: Charles Messman Investor Relations 412-837-5300 IR@smithmicro.com Smith Micro Reports Third Quarter 2026 Financial Results PITTSBURGH, PA, November 12, 2026 – Smith Micro Software, Inc. ( Nasdaq: SMSI ) (“Smith Micro” or the “Company”) today reported fi

$NOKMed

LightCounting:: November 2026 Nokia SReXperts

Nokia hosted its SReXperts/Wavelengths conference in November 2026, focusing on AI's impact on connectivity and its solutions for customers. The company reported strong Q3 2026 earnings, with AI & Cloud sales doubling year-over-year and $1.7 billion in new orders. Nokia expects 25-30% growth in its Optical and IP Networks businesses in 2027. The company aims to help telecom operators adapt to AI-driven changes and capitalize on new opportunities.

$IBRXLow

IBRX Stock Eyes Best Year Ever: Founder Teases 12 Months Of ‘Stealth’ NantWorks Reveals — Cancer Tech, AI Chips And Satellites

ImmunityBio (IBRX) reported a 53% increase in Q3 net product revenue to $48.7M, with 92% growth for the first nine months. The company is testing its drug Anktiva for sepsis and aims to expand FDA approval for bladder cancer. NantWorks, led by Patrick Soon-Shiong, plans a blockchain-based exchange for tokenized securities. IBRX stock has risen 195% over the past year, with bullish retail sentiment on Stocktwits.